Cetuximab inhibits cisplatin-induced activation of EGFR signaling in esophageal squamous cell carcinoma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Cetuximab inhibits cisplatin-induced activation of EGFR signaling in esophageal squamous cell carcinoma

Published:2014-07-03 Issue:3 Volume:32 Page:1188-1192
ISSN:1021-335X
Container-title:Oncology Reports
language:en
Short-container-title:

Author:

KWON JUNHYE,YOON HYEON-JOON,KIM JI-HEE,LEE TAE SUP,SONG IN HO,LEE HAE WON,KANG MOON CHUL,PARK JONG HO

Publisher

Spandidos Publications

Subject

Cancer Research,Oncology,General Medicine

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A mechanistic assessment of the nature of pharmacodynamic drug-drug interaction in vivo and in vitro;In Silico Pharmacology;2023-10-27

2. Periostin derived from cancer-associated fibroblasts promotes esophageal squamous cell carcinoma progression via ADAM17 activation;Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease;2023-06

3. Advances and challenges in the treatment of esophageal cancer;Acta Pharmaceutica Sinica B;2021-11

4. Interactions between anti-EGFR therapies and cytotoxic chemotherapy in oesophageal squamous cell carcinoma: why clinical trials might have failed and how they could succeed;Cancer Chemotherapy and Pharmacology;2020-11-09

5. Nimotuzumab Plus Paclitaxel and Cisplatin as a 1st-Line Treatment for Esophageal Cancer: Long Term Follow-up of a Phase II Study;Journal of Cancer;2019

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP